Inhibition of P53 and up-regulation of GLUT4 improve glucose metabolism disorder and reduce apoptosis of cardiomyocytes induced by high glucose combined with ische-mia-hypoxia
ZHANG Jixin,LIU Fen,ZHANG Tong,ZHANG Xuehe,FANG Binbin,LI Xiaomei,YANG Yining
DOI: https://doi.org/10.20039/j.cnki.1007-3949.2023.03.005
2023-01-01
Abstract:Aim To explore whether inhibiting P53 and increasing the expression of glucose transporter 4(GLUT4) in cardiomyocytes can improve glucose metabolism disorder and reduce apoptosis induced by high glucose(HG) combined with ischemia-hypoxia(IH). Methods The cardiomyocyte HG+IH model was induced in vitro. The experimental groups were the control group, HG group, IH group, HG+IH group, HG+IH+P53 inhibitor group(HG+IH+Pifithrin-α group), HG+IH+P53 inhibitor+GLUT4 inhibitor group(HG+IH+Pifithrin-α+Fasentin group). Cell viability was detected by the CCK-8 method, lactate dehydrogenase(LDH), glycolytic key enzyme activity, and ATP content were detected by the kit, protein expression of P53, GLUT4, Bax/Bcl-2 and Caspase-3 were detected by Western blot, and cardiomyocyte apoptosis was detected by flow cytometry. Results(1)In the HG+IH cardiomyocyte model in vitro, compared with the control group, the expression of P53 increased by 75%, the expression of GLUT4 decreased by 16%, the content of ATP decreased by 51%, the cell viability decreased by 45%, the LDH activity increased by 3.6 times, the expression of Caspase-3 and Bax/Bcl-2 increased by 54% and 77% respectively, and the apoptosis rate increased(all P<0.05).(2)After inhibiting the expression of P53 in cardiomyocytes, compared with the HG+IH group, the expression of GLUT4 in cardiomyocytes increased by 34%, the content of ATP increased by 60%, the cell viability increased by 50%, the LDH activity decreased by 13%, the expression of Caspase-3 and Bax/Bcl-2 decreased by 31% and 53% respectively, and the apoptosis rate decreased in HG+IH+Pifithrin-α group(all P<0.05).(3)After inhibiting GLUT4, compared with the HG+IH+Pifithrin-α group, the expression of GLUT4 in cardiomyocytes decreased by 22%, the content of ATP decreased by 39%, the cell viability decreased by 25%, the LDH activity increased by 21%, the expression of Caspase-3 and Bax/Bcl-2 increased by 43% and 89% respectively, and the apoptosis rate increased(all P<0.05).Conclusions In the cardiomyocyte model of high glucose combined with ischemia-hypoxia, inhibiting P53 can increase the expression of GLUT4, improve the glucose metabolism disorder of cardiomyocytes induced by high glucose combined with ischemia-hypoxia, and reduce apoptosis.